Active Comparator Biological/Vaccine,Active Comparator Biological/Vaccine

13 trials

Sponsors

Faculty of Medicine Chulalongkorn university, The Thrasher Research Fund, Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital, Ratchadapisek Sompoch Endowment Fund, Ratchaphisek Sompoch Grant

Conditions

Allergy Hepatitis A Prevalence of hepatitis A Hepatitis A vaccine Three doses of hepatitis A vaccine Kidney transplant recipientsClearance of warts warts , tuberculin purified protein derivative (PPD), measles, mumps, rubella (MMR) vaccine , intralesionalFacial fine wrinkles, enlarged pores, and skin laxity in healthy individuals seeking facial rejuvenation. The study focuses on age-related skin changes equally present on both sides of the face. Platelet-rich plasma, Platelet-rich fibrin, Skin rejuvenationHealthy Thai infants aged 9-12 months Healthy, InfantHealthy male and female subjects Healthy male and female subjectsHealthy participants with no health conditions or stable chronic diseases. -Immunogenicity and safety of high-dose influenza vaccine in people living with HIV who has low CD4 count. Influenza, Vaccination, HIVInterference of maternal antibodies on infants immune responses pertussis acellular vaccine whole cell pertussis vaccine antibody responses cellular immune responses

Early Phase 1

EFFECT OF CD8+ T CELL ACTIVATION ON LIVE ATTENUATED HEPATITIS A VACCINE IN OBESITY/OVERWEIGHT CHILDREN AND YOUNG ADULTS

Active, not recruitingTCTR20210825005

Ratchaphisek Sompoch GrantObesity Overweight Normal weight Children Lived attenuated hepatitis A vaccine CD8 T cell IFN gamma Obesity

Start: 2021-08-25Target: 200Updated: 2026-03-30

Phase 1

Effectiveness of Autologous Platelet Rich Plasma Compared with liquid Platelet Rich Fibrin Intradermal Injection for Facial Skin Rejuvenation

RecruitingTCTR20250625006

Institute of dermatology, ThailandFacial fine wrinkles, enlarged pores, and skin laxity in healthy individuals seeking facial rejuvenation. The study focuses on age-related skin changes equally present on both sides of the face. Platelet-rich plasma, Platelet-rich fibrin, Skin rejuvenation

Start: 2025-05-05Target: 8Updated: 2026-03-30

Phase 2

A Phase 2 Double-blind, Randomized, Controlled Trial to Assess the Safety and Immunogenicity of 10 mcg HXP-GPOVac Vaccine in Healthy Volunteers

Active, not recruitingTCTR20220804007

The Government Pharmaceutical OrganizationHealthy male and female subjects Healthy male and female subjects

Start: 2022-08-19Target: 300Updated: 2026-03-30

Phase 3

Intralesional measles, mumps, rubella (MMR) vaccine versus tuberculin purified protein derivative (PPD) in the treatment of palmoplantar and periungual warts: A randomized controlled trial

Active, not recruitingTCTR20200604014

Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospitalClearance of warts warts , tuberculin purified protein derivative (PPD), measles, mumps, rubella (MMR) vaccine , intralesional

Start: 2020-06-02Target: 40Updated: 2026-03-30

Immune response to pre-exposure rabies vaccination via intradermal route compared to intramuscular in kidney transplant recipients

RecruitingTCTR20200716006

Ratchadapisek Sompoch Endowment FundRabies neutralizing antibody Rabies vaccination Kidney transplant recipient Immune response

Start: 2020-02-03Updated: 2026-03-30

Immunogenicity of a single standard dose versus a double standard dose of inactivated trivalent influenza vaccine in patients on peritoneal dialysis: Open labelled Randomized control trial

TCTR20220526003

Health Systems Research Institute(HSRI)

Start: 2022-07-04Target: 125Updated: 2026-03-30

Phase 3 study, to evaluate the safety and immunogenicity of 10 mcg HXP-GPOVac COVID-19 vaccine boost in comparison to a viral vector-based COVID-19 vaccines

TCTR20221026004

The Government Pharmaceutical OrganizationHealthy male and female subjects Healthy male and female subjects

Start: 2022-12-23Target: 4000Updated: 2026-03-30

Immunogenicity and Safety of High-dose Influenza Vaccine in People Living With HIV/AIDS and Low CD4 Count

RecruitingTCTR20250910008

Faculty of Medicine, Chiang Mai University, ThailandImmunogenicity and safety of high-dose influenza vaccine in people living with HIV who has low CD4 count. Influenza, Vaccination, HIV

Start: 2025-09-05Target: 86Updated: 2026-03-30

Phase 4

Comparative Effectiveness of Two Doses Versus Three Doses of Hepatitis A Vaccine in Kidney transplant recipients in Chulalongkorn hospital

RecruitingTCTR20180325001

Faculty of Medicine Chulalongkorn universityAllergy Hepatitis A Prevalence of hepatitis A Hepatitis A vaccine Three doses of hepatitis A vaccine Kidney transplant recipients

Start: 2016-07-01Target: 400Updated: 2026-03-30

Vaccine responses in infants after acellular pertussis vaccination during pregnancy in Thailand

Active, not recruitingTCTR20180926001

The Thrasher Research FundInterference of maternal antibodies on infants immune responses pertussis acellular vaccine whole cell pertussis vaccine antibody responses cellular immune responses

Start: 2015-04-02Target: 370Updated: 2026-02-02

Immunogenicity and Safety of Pneumococcal 13-valent Conjugate Vaccine between Weuphoria and Prevnar 13 in Thai Older People

Active, not recruitingTCTR20230923001

National Vaccine Institute (NVI)Healthy participants with no health conditions or stable chronic diseases. -

Start: 2025-11-01Target: 408Updated: 2026-03-30

A Phase IV, Non-Inferiority, Double Blind, Randomized Controlled Clinical Trial comparing Safety and Immunogenicity of SII-Measles-Mumps-Rubella vaccine with Priorix (GSK) in healthy infants

Active, not recruitingTCTR20231108008

MASU Co., LtdHealthy Thai infants aged 9-12 months Healthy, Infant

Start: 2024-01-01Target: 250Updated: 2026-03-30

Comparison of Hepatitis B surface Antibody levels after vaccination with combined one dose hexavalent-based vaccine (DTaP-IPV-HB-Hib) with two doses of pentavalent-based vaccine (DTwP-HB-Hib) versus three doses of pentavalent-based vaccine (DTwP-HB-Hib)

Active, not recruitingTCTR20240513002

Research center, Faculty of Medicine Ramathibodi Hospital, Mahidol UniversityThe anti-HBs antibody levels after vaccination with combined one dose hexavalent-based vaccine (DTaP-IPV-HB-Hib) with two doses of pentavalent-based vaccine (DTwP-HB-Hib) versus three doses of pentavalent-based vaccine (DTwP-HB-Hib) at 3-6 months after the last dose of vaccination. HBV hepatitis B virus GMT geometric mean PCV pneumococcal conjugated vaccine

Start: 2022-05-24Target: 80Updated: 2026-03-30